Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹892.10
Market cap: ₹393.7 Cr
Revenue (annual): ₹168.7 Cr
Net profit (annual): ₹34.74 Cr
P/E (TTM): 12.0×Sector 47.4×
Promoter holding: 46.62%-0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 4 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Dividend 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 May 2026 14:59 IST BSE

Dividend

Jenburkt Pharmaceuticals Dividend

Jenburkt Pharmaceuticals has fixed August 28, 2026, as the record date for its FY 2025-26 dividend. Payment is scheduled within 30 days of the AGM on September 4, 2026. The same date serves as the cut-off for e-voting eligibility.

Execution: within 30 days from 4th September 2026

Read the filing ↗